COM:ABCELLERA
AbCellera Biologics Inc.
- Stock
Last Close
2.72
22/11 21:00
Market Cap
823.35M
Beta: -
Volume Today
2.82K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
asset turnover | 0.41 - | 0.49 20.31% | 0.23 53.10% | 0.28 22.72% | 0.32 10.71% | 0.03 91.89% | |
cash conversion cycle | 83.74 - | -87.13 204.05% | -144.69 66.06% | 329.70 327.87% | |||
cash per share | 0.05 - | 0.04 27.68% | 3.73 10,543.94% | 2.62 29.75% | 3.11 18.62% | 2.63 15.42% | |
company equity multiplier | 1.85 - | 2.29 23.75% | 1.21 47.15% | 1.29 6.17% | 1.25 2.80% | 1.29 3.36% | |
days of inventory outstanding | 18.93 - | 13.41 29.18% | 8.42 37.23% | 13.08 55.39% | |||
days of payables outstanding | 269.01 - | 256.75 4.56% | 182.13 29.06% | 301.38 65.48% | |||
days of sales outstanding | 172.25 - | 137.61 20.11% | 333.82 142.58% | 156.21 53.21% | 29.02 81.42% | 618.00 2,029.65% | |
dividend yield | |||||||
ebit per revenue | -0.09 - | -0.35 315.82% | 0.67 288.74% | 0.54 18.59% | 0.45 18.13% | -6.24 1,498.62% | |
ebt per ebit | -0.41 - | 0.54 230.85% | 1.01 88.38% | 1.07 5.98% | 1.10 3.01% | 0.73 33.57% | |
effective tax rate | 4.12 - | -0.09 102.29% | 0.25 360.55% | 0.30 21.56% | 0.34 12.44% | 0.16 52.89% | |
enterprise value multiple | 7.04K - | -37.24K 628.93% | 34.24 100.09% | 14.45 57.80% | 9.35 35.28% | -8.30 188.77% | |
fixed asset turnover | 1.40 - | 1.37 1.85% | 13.01 850.03% | 3.36 74.16% | 2.23 33.53% | 0.13 94.08% | |
free cash flow per share | -0.01 - | -0.01 25.19% | 0.05 932.45% | 0.67 1,240.30% | 0.72 6.39% | -0.42 158.46% | |
gross profit margin | 1 - | 1 0% | 0.88 11.64% | 0.88 0.55% | 0.86 1.77% | 0.19 78.27% | |
interest coverage | -3.55 - | -19.68 454.08% | 23.96 221.77% | 39.12 63.25% | 53.53 36.82% | ||
inventory turnover | 19.28 - | 27.22 41.21% | 43.37 59.30% | 27.91 35.65% | |||
long term debt to capitalization | 0.07 - | 0.28 285.97% | 0.01 97.48% | 0.03 384.94% | 0.06 70.74% | 0.06 0.55% | |
net income per ebt | 1 - | 1.09 9.46% | 0.75 31.17% | 0.70 7.06% | 0.66 5.32% | 0.84 26.88% | |
net profit margin | 0.03 - | -0.21 695.60% | 0.51 344.74% | 0.41 19.81% | 0.33 20.16% | -3.85 1,278.98% | |
operating cash flow per share | 0.02 - | 0.01 24.44% | 0.14 1,039.80% | 0.89 522.28% | 0.97 9.70% | -0.15 115.59% | |
operating cycle | 352.76 - | 169.62 51.92% | 37.44 77.93% | 631.08 1,585.77% | |||
operating profit margin | -0.09 - | -0.35 315.82% | 0.67 288.74% | 0.54 18.59% | 0.45 18.13% | -6.24 1,498.62% | |
payables turnover | 1.36 - | 1.42 4.78% | 2.00 40.97% | 1.21 39.57% | |||
pretax profit margin | 0.03 - | -0.19 644.11% | 0.68 455.56% | 0.58 13.72% | 0.49 15.67% | -4.58 1,029.17% | |
price fair value | 1.09K - | 1.24K 13.24% | 7.71 99.38% | 3.84 50.16% | 2.34 39.10% | 1.43 38.80% | |
receivables turnover | 2.12 - | 2.65 25.17% | 1.09 58.78% | 2.34 113.70% | 12.58 438.30% | 0.59 95.30% | |
return on assets | 0.01 - | -0.10 816.59% | 0.12 214.79% | 0.12 1.59% | 0.10 11.61% | -0.10 195.63% | |
return on capital employed | -0.05 - | -0.26 428.01% | 0.17 165.51% | 0.17 1.35% | 0.15 10.81% | -0.17 213.84% | |
return on equity | 0.03 - | -0.24 986.80% | 0.14 160.66% | 0.15 4.49% | 0.13 14.09% | -0.13 198.84% | |
total debt to capitalization | 0.23 - | 0.40 75.75% | 0.01 98.19% | 0.04 415.31% | 0.06 66.34% | 0.06 0.64% |
All numbers in USD (except ratios and percentages)